Notice of Meeting of Chronic Hazard Advisory Panel on Phthalates, 18165-18166 [2010-8144]

Download as PDF Federal Register / Vol. 75, No. 68 / Friday, April 9, 2010 / Notices the objectives of the Javits-WagnerO’Day Act (41 U.S.C. 46–48c) in connection with the products proposed for deletion from the Procurement List. End of Certification The following products are proposed for deletion from the Procurement List: Products Scarf, Branch of Service NSN: 8455–00–916–8398 NPA: UNKNOWN Contracting Activity: Defense Supply Center Philadelphia, Philadelphia, PA. Solvent, Correction Fluid NSN: 7510–01–333–6241 NPA: Lighthouse for the Blind, St. Louis, MO Contracting Activity: Federal Acquisition Service, GSA/FSS OFC SUP Ctr—Paper Products, New York, NY. Patricia Briscoe, Deputy Director, Business Operations. [FR Doc. 2010–8095 Filed 4–8–10; 8:45 am] BILLING CODE 6353–01–P CONSUMER PRODUCT SAFETY COMMISSION Notice of Meeting of Chronic Hazard Advisory Panel on Phthalates srobinson on DSKHWCL6B1PROD with NOTICES AGENCY: Consumer Product Safety Commission. ACTION: Notice of meeting. SUMMARY: The Consumer Product Safety Commission (Commission) announces the first meeting of the Chronic Hazard Advisory Panel (CHAP) on Phthalates. The Commission appointed this CHAP to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles, pursuant to section 108 of the Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 110–314). DATES: The meeting will be held from 9 a.m. to 5 p.m. on Wednesday, April 14 and from 9 a.m. to 4 p.m. on Thursday, April 15, 2010. ADDRESSES: The meeting will be held in the fourth floor hearing room in the Commission’s offices at 4330 East West Highway, Bethesda, Maryland. Online Registration: Members of the public who wish to attend the meeting are requested to preregister online at https://www.cpsc.gov/cgibin/chap.aspx. This meeting will also be available live via Web cast at https://www.cpsc.gov/ webcast. Registration is not necessary to view the Web cast. FOR FURTHER INFORMATION CONTACT: Michael Babich, Directorate for Health Sciences, Consumer Product Safety VerDate Nov<24>2008 17:07 Apr 08, 2010 Jkt 220001 Commission, Bethesda, MD 20814; telephone (301) 504–7253; e-mail mbabich@cpsc.gov. SUPPLEMENTARY INFORMATION: The Commission has previously investigated potential risks posed to children from phthalate plasticizers, especially di(2ethylhexyl) phthalate (DEHP) and diisononyl phthalate (DINP), which were used to soften some children’s teethers, rattles, and toys made from polyvinyl chloride (PVC). Phthalates can leach from such products when they are mouthed by children, causing some phthalates to be ingested. In addition, children and adults can be exposed to phthalates from many sources, including consumer products, food, cosmetics, medical devices, and the environment. Certain phthalates have been shown to cause adverse health effects, including birth defects, in laboratory animals. Section 108 of the CPSIA permanently prohibits the sale of any ‘‘children’s toy or child care article’’ containing more than 0.1 percent of three specified phthalates—DEHP, dibutyl phthalate (DBP), and benzyl butyl phthalate (BBP). Section 108 of the CPSIA also prohibits, on an interim basis, the sale of ‘‘toys that can be placed in a child’s mouth’’ or ‘‘child care articles’’ containing more than 0.1 percent of three additional phthalates—DINP, diisodecyl phthalate (DIDP), and di-noctyl phthalate (DNOP). Moreover, section 108 of the CPSIA requires the Commission to convene a CHAP ‘‘to study the effects on children’s health of all phthalates and phthalate alternatives as used in children’s toys and child care articles.’’ The CPSIA requires the CHAP to complete an examination of the full range of phthalates that are used in products for children and to: (i) Examine all of the potential health effects (including endocrine disrupting effects) of the full range of phthalates; (ii) consider the potential health effects of each of these phthalates both in isolation and in combination with other phthalates; (iii) examine the likely levels of children’s, pregnant women’s, and others’ exposure to phthalates, based on a reasonable estimation of normal and foreseeable use and abuse of such products; (iv) consider the cumulative effect of total exposure to phthalates, both from children’s products and from other sources, such as personal care products; (v) review all relevant data, including the most recent, best-available, peerreviewed, scientific studies of these phthalates and phthalate alternatives that employ objective data collection practices or employ other objective PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 18165 methods; (vi) consider the health effects of phthalates not only from ingestion but also as a result of dermal, hand-tomouth, or other exposure; (vii) consider the level at which there is a reasonable certainty of no harm to children, pregnant women, or other susceptible individuals and their offspring, considering the best available science, and using sufficient safety factors to account for uncertainties regarding exposure and susceptibility of children, pregnant women, and other potentially susceptible individuals; and (viii) consider possible similar health effects of phthalate alternatives used in children’s toys and child care articles. The CHAP’s examination must be conducted de novo, and the statute contemplates completion of its examination within 18 months of appointment of the CHAP. The CHAP must review prior work on phthalates by the Commission, but the Commission’s prior work is not to be considered determinative. The CHAP must make recommendations to the Commission regarding any phthalates (or combinations of phthalates) in addition to those identified in section 108 of the CPSIA or phthalate alternatives that the panel determines should be declared banned hazardous substances. The Commission selected the CHAP members from scientists nominated by the National Academy of Sciences. See 15 U.S.C. 2077, 2030(b). The first meeting of the CHAP on Phthalates will be held on April 14 and 15, 2010, in the fourth floor hearing room at the Commission’s offices at 4330 East West Highway, Bethesda, Maryland. The meeting will begin at 9 a.m. both days and is scheduled to end at 5 p.m. on April 14 and 4 p.m. on April 15. The meeting is open to the public, space permitting, but no opportunity for public participation in the first meeting is scheduled. There will be an opportunity in connection with the second meeting of the CHAP for presentation of oral and written data and views (date to be announced). At the first CHAP meeting, the CHAP will choose its Chair and Vice Chair and the CPSC staff will present information on the history of the phthalates project, the scope of the CHAP on phthalates, including a review of the de novo examination called for in section 108 (b)(2)(B)(i) through (vii) of the CPSIA, and the CPSC staff’s toxicity reviews and other work on phthalates. During the remainder of the meeting, the CHAP will consider how it will proceed and begin its deliberations. E:\FR\FM\09APN1.SGM 09APN1 18166 Federal Register / Vol. 75, No. 68 / Friday, April 9, 2010 / Notices Dated: April 6, 2010. Todd A. Stevenson, Secretary, Consumer Product Safety Commission. doctoral degrees in the biomedical sciences and public health. The Acting President, USU; the Vice President, USU Office of Research; and the President, Henry M. Jackson Foundation for the Advancement of Military Medicine, will also present reports. These actions are necessary for the University to pursue its mission, which is to provide outstanding health care practitioners and scientists to the uniformed services. [FR Doc. 2010–8144 Filed 4–8–10; 8:45 am] BILLING CODE 6355–01–P DEPARTMENT OF DEFENSE Office of the Secretary Federal Advisory Committee; Board of Regents of the Uniformed Services University of the Health Sciences AGENCY: Uniformed Services University of the Health Sciences (USU), DoD. ACTION: Quarterly meeting notice. SUMMARY: Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended) and the Sunshine in the Government Act of 1976 (5 U.S.C. 552b, as amended), this notice announces a meeting of the Board of Regents of the Uniformed Services University of the Health Sciences (USU) on May 14, 2010. DATES: The meeting will be held on Friday, May 14, 2010, from: 9 a.m. to 11:30 a.m. (Open Session). 11:30 a.m. to 12:30 p.m. (Closed Session). 12:30 p.m. to 3:30 p.m. (Open Session). ADDRESSES: The meeting will be held at the Everett Alvarez Jr. Board of Regents Room (D3001), Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, Maryland 20814. FOR FURTHER INFORMATION CONTACT: Janet S. Taylor, Designated Federal Official, 4301 Jones Bridge Road, Bethesda, Maryland 20814; telephone 301–295–3066. Ms. Taylor can also provide base access procedures. SUPPLEMENTARY INFORMATION: Purpose of the Meeting srobinson on DSKHWCL6B1PROD with NOTICES Written Statements Interested persons may submit a written statement for consideration by the Board of Regents. Individuals submitting a written statement must submit their statement to the Designated Federal Official (see FOR FURTHER INFORMATION CONTACT). If such statement is not received at least 10 calendar days prior to the meeting, it may not be provided to or considered by the Board of Regents until its next open meeting. The Designated Federal Official will review all timely submissions with the Board of Regents Chairman and ensure such submissions are provided to Board of Regents Members before the meeting. After reviewing the written comments, submitters may be invited to orally present their issues during the May 2010 meeting or at a future meeting. Dated: April 5, 2010. Mitchell S. Bryman, Alternate OSD Federal Register Liaison Officer, Department of Defense. BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Department of the Army, Corps of Engineers Agenda The actions that will take place include the approval of minutes from the Board of Regents Meeting held February 2, 2010; acceptance of reports from working committees; approval of faculty appointments and promotions; and the awarding of post-baccalaureate degrees as follows: Doctor of Medicine, Ph.D. in Nursing Science, Master of Science in Nursing, and master’s and 17:07 Apr 08, 2010 Pursuant to Federal statute and regulations (5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102– 3.165) and the availability of space, most of the meeting is open to the public. Seating is on a first-come basis. The closed portion of this meeting is authorized by 5 U.S.C. 552b(c)(6) as the subject matter involves personal and private observations. [FR Doc. 2010–8052 Filed 4–8–10; 8:45 am] Meetings of the Board of Regents assure that USU operates in the best traditions of academia. An outside Board is necessary for institutional accreditation. VerDate Nov<24>2008 Meeting Accessibility Jkt 220001 Notice of Availability of the Draft Supplemental Environmental Impact Statement for the Proposed Baseload Power Plant, East Kentucky Power Cooperative, Inc., Clark County, KY AGENCY: U.S. Army Corps of Engineers, DoD. ACTION: PO 00000 Notice of availability. Frm 00023 Fmt 4703 Sfmt 4703 SUMMARY: The U.S. Army Corps of Engineers (USACE), in accordance with 42 U.S.C. 4321 to 4370(f), is issuing this notice to advise the public that a Draft Supplemental Environmental Impact Statement (SEIS) has been prepared and is available for review and comment. DATES: Written comments on the Draft SEIS will be accepted for 45 days following publication of the Environmental Protection Agency’s notice of availability for the Draft SEIS in the Federal Register. The USACE will hold a public hearing at 7 p.m. (EDT) on June 8, 2010. ADDRESSES: The Draft SEIS can be viewed online at: https:// www.ekpc.coop/smith-unit1.html. The Draft SEIS will also be available for viewing at the locations listed in the SUPPLEMENTARY INFORMATION section. Comments should be submitted to Mr. Michael Hasty, Acting Chief, South Section, Regulatory Branch, Louisville District, P.O. Box 59, Louisville, KY 40201–0059. The Public Hearing will be held at the Clark County Extension Service office located at 1400 Fortune Drive in Winchester KY 40391. FOR FURTHER INFORMATION CONTACT: Mr. Michael Hasty, Acting Chief, South Section, Regulatory Branch, Louisville District, P.O. Box 59, Louisville, KY 40201–0059. Phone (502) 315–6676, email: michael.d.hasty@usace.army.mil. SUPPLEMENTARY INFORMATION: A final EIS and Record of Decision was prepared by the U.S. Department of Energy in 2002/2003 for a proposed 540 megawatt coal-fired integrated gasification combined cycle (IGCC) electric generating plant at the same location, the Smith Site. That project, known as the Kentucky Pioneer IGCC Demonstration Project, was never built. The Corps has reviewed the EIS prepared by DOE and, based on similarities between the two projects, has determined to adopt that EIS as the basis for review of the current proposal. The Corps is preparing this Supplemental EIS (SEIS) to evaluate those aspects of the current proposal that are not substantially similar to the DOE project, as a result of changes in project parameters, existing environmental conditions, and relevant laws and regulations. East Kentucky Power Cooperative, Inc. (EKPC) has applied for a Department of the Army (DA) permit from the U.S. Army Corps of Engineers (Corps) to authorize unavoidable impacts to jurisdictional waters of the U.S. pursuant to Section 404 of the Clean Water Act (Section 404) and Section 10 of the Rivers and Harbors Act (Section 10). E:\FR\FM\09APN1.SGM 09APN1

Agencies

[Federal Register Volume 75, Number 68 (Friday, April 9, 2010)]
[Notices]
[Pages 18165-18166]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8144]


=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION


Notice of Meeting of Chronic Hazard Advisory Panel on Phthalates

AGENCY: Consumer Product Safety Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The Consumer Product Safety Commission (Commission) announces 
the first meeting of the Chronic Hazard Advisory Panel (CHAP) on 
Phthalates. The Commission appointed this CHAP to study the effects on 
children's health of all phthalates and phthalate alternatives as used 
in children's toys and child care articles, pursuant to section 108 of 
the Consumer Product Safety Improvement Act of 2008 (CPSIA) (Pub. L. 
110-314).

DATES: The meeting will be held from 9 a.m. to 5 p.m. on Wednesday, 
April 14 and from 9 a.m. to 4 p.m. on Thursday, April 15, 2010.

ADDRESSES: The meeting will be held in the fourth floor hearing room in 
the Commission's offices at 4330 East West Highway, Bethesda, Maryland.
    Online Registration: Members of the public who wish to attend the 
meeting are requested to preregister online at https://www.cpsc.gov/cgibin/chap.aspx. This meeting will also be available live via Web cast 
at https://www.cpsc.gov/webcast. Registration is not necessary to view 
the Web cast.

FOR FURTHER INFORMATION CONTACT: Michael Babich, Directorate for Health 
Sciences, Consumer Product Safety Commission, Bethesda, MD 20814; 
telephone (301) 504-7253; e-mail mbabich@cpsc.gov.

SUPPLEMENTARY INFORMATION: The Commission has previously investigated 
potential risks posed to children from phthalate plasticizers, 
especially di(2-ethylhexyl) phthalate (DEHP) and diisononyl phthalate 
(DINP), which were used to soften some children's teethers, rattles, 
and toys made from polyvinyl chloride (PVC). Phthalates can leach from 
such products when they are mouthed by children, causing some 
phthalates to be ingested. In addition, children and adults can be 
exposed to phthalates from many sources, including consumer products, 
food, cosmetics, medical devices, and the environment. Certain 
phthalates have been shown to cause adverse health effects, including 
birth defects, in laboratory animals.
    Section 108 of the CPSIA permanently prohibits the sale of any 
``children's toy or child care article'' containing more than 0.1 
percent of three specified phthalates--DEHP, dibutyl phthalate (DBP), 
and benzyl butyl phthalate (BBP). Section 108 of the CPSIA also 
prohibits, on an interim basis, the sale of ``toys that can be placed 
in a child's mouth'' or ``child care articles'' containing more than 
0.1 percent of three additional phthalates--DINP, diisodecyl phthalate 
(DIDP), and di-n-octyl phthalate (DNOP).
    Moreover, section 108 of the CPSIA requires the Commission to 
convene a CHAP ``to study the effects on children's health of all 
phthalates and phthalate alternatives as used in children's toys and 
child care articles.'' The CPSIA requires the CHAP to complete an 
examination of the full range of phthalates that are used in products 
for children and to: (i) Examine all of the potential health effects 
(including endocrine disrupting effects) of the full range of 
phthalates; (ii) consider the potential health effects of each of these 
phthalates both in isolation and in combination with other phthalates; 
(iii) examine the likely levels of children's, pregnant women's, and 
others' exposure to phthalates, based on a reasonable estimation of 
normal and foreseeable use and abuse of such products; (iv) consider 
the cumulative effect of total exposure to phthalates, both from 
children's products and from other sources, such as personal care 
products; (v) review all relevant data, including the most recent, 
best-available, peer-reviewed, scientific studies of these phthalates 
and phthalate alternatives that employ objective data collection 
practices or employ other objective methods; (vi) consider the health 
effects of phthalates not only from ingestion but also as a result of 
dermal, hand-to-mouth, or other exposure; (vii) consider the level at 
which there is a reasonable certainty of no harm to children, pregnant 
women, or other susceptible individuals and their offspring, 
considering the best available science, and using sufficient safety 
factors to account for uncertainties regarding exposure and 
susceptibility of children, pregnant women, and other potentially 
susceptible individuals; and (viii) consider possible similar health 
effects of phthalate alternatives used in children's toys and child 
care articles.
    The CHAP's examination must be conducted de novo, and the statute 
contemplates completion of its examination within 18 months of 
appointment of the CHAP. The CHAP must review prior work on phthalates 
by the Commission, but the Commission's prior work is not to be 
considered determinative.
    The CHAP must make recommendations to the Commission regarding any 
phthalates (or combinations of phthalates) in addition to those 
identified in section 108 of the CPSIA or phthalate alternatives that 
the panel determines should be declared banned hazardous substances. 
The Commission selected the CHAP members from scientists nominated by 
the National Academy of Sciences. See 15 U.S.C. 2077, 2030(b).
    The first meeting of the CHAP on Phthalates will be held on April 
14 and 15, 2010, in the fourth floor hearing room at the Commission's 
offices at 4330 East West Highway, Bethesda, Maryland. The meeting will 
begin at 9 a.m. both days and is scheduled to end at 5 p.m. on April 14 
and 4 p.m. on April 15. The meeting is open to the public, space 
permitting, but no opportunity for public participation in the first 
meeting is scheduled. There will be an opportunity in connection with 
the second meeting of the CHAP for presentation of oral and written 
data and views (date to be announced).
    At the first CHAP meeting, the CHAP will choose its Chair and Vice 
Chair and the CPSC staff will present information on the history of the 
phthalates project, the scope of the CHAP on phthalates, including a 
review of the de novo examination called for in section 108 
(b)(2)(B)(i) through (vii) of the CPSIA, and the CPSC staff's toxicity 
reviews and other work on phthalates. During the remainder of the 
meeting, the CHAP will consider how it will proceed and begin its 
deliberations.


[[Page 18166]]


    Dated: April 6, 2010.
Todd A. Stevenson,
Secretary, Consumer Product Safety Commission.
[FR Doc. 2010-8144 Filed 4-8-10; 8:45 am]
BILLING CODE 6355-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.